Victory Capital Management Inc Age X Therapeutics, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$0.68 - $1.13 $2,483 - $4,126	-3,652 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$0.78 - $1.95 $64 - $161	-83 Reduced 2.22%	3,652 $3,000
Q4 2019 Feb 04, 2020	SELL	$1.25 - $1.82 $32 - $47	-26 Reduced 0.69%	3,735 $5,000
Q3 2019 Nov 12, 2019	BUY	$1.96 - $3.38 $7,371 - $12,712	3,761 New	3,761 $7,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.